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Introduction 
With a progressively ageing and physically 
active population, joint ailments appear as 
responsible for activity limitation in adults 18-65 
years of age, resulting in reduced quality of life 
and high socio-economic burden. Despite 
intensive efforts on the development of cartilage 
repair strategies worldwide, no current approach 
has proven full efficacy. In this work, it is 
proposed a novel one-step combined therapy 
where human adipose-derived stem/stromal cells 
(hASC)1 develop cartilage-like tissue within a 
novel hydrogel based on methacrylated gellan 
gum2 (mimsys® G).  A complete xeno-free 
approach was developed and both in vitro and in 
vivo experiments were conducted to evaluate the 
performance of this system for focal cartilage 
repair.   
 
Materials and Methods 
Human ASC (hASC xeno-free, irisbiosciences, 
Portugal) were expanded in xeno-free media 
until sub-confluency. mimsys G hydrogel 
(mimsys® G, irisbiosciencies) was prepared to 
yield a 2% w/V solution. Cells were 
encapsulated at 10x106 cells/mL, ionically 
crosslinked and cultured with or without 
chondrogenic induction for 21 days. Cell 
viability was determined by live/dead assay, and 
cell metabolic activity by MTS reduction. A in 
vivo study evaluated regeneration of focal 
cartilage lesions on a rabbit knee model for 8 
weeks, using an autologous approach. 
Chondrogenic development was assessed on 
both in vitro and in vivo samples by histological 
staining of cartilage matrix using safranin O and 
immunolocalization of col-II. Expression of 
chondrogenic-related genes such as aggrecan, 
col-II and sox-9 (Applied Biosystems) were also 
determined at different time points.   
 
Results 
In vitro analysis of the combined system 
demonstrated high viability of the cells and 
progressive metabolic activity along culture 
(Fig.1A). Additionally, intense cartilage matrix 
deposition was detected by safranin O staining 
(Fig.1B). Correspondent up-regulation of 
chondrogenic genes were quantified. As for in 
vivo performance, analysis of rabbit cartilage 
lesion explants demonstrated filling of the defect 




Fig.1 Safranin-O staining of combined system: 
A. After in vitro chondrogenic induction.  
B. After in vivo regeneration of cartilage lesion. 
 
Discussion and Conclusions 
The proposed one-step combined therapy system 
demonstrated both safety and efficacy in vitro, 
revealed respectively, by high cell viability and 
intense cartilage development, demonstrated by 
expression of specific hyaline cartilage markers. 
The in vivo study revealed promising repair 
performance in focal cartilage lesions, 
suggesting a valuable approach for further 
therapeutic exploitation.     
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